View in EDS HTML Full Text PDF Full Text

A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.

Saved in:
Bibliographic Details
Title: A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.
Authors: Pu JJ; Division of Medicine, VA Boston Healthcare System, Boston, MA, United States.; Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States., Berger KN; New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY, United States., Zheng C; Division of Medicine, VA Boston Healthcare System, Boston, MA, United States.; Department of Medicine, Boston University School of Medicine, Boston, MA, United States., Do N; Division of Medicine, VA Boston Healthcare System, Boston, MA, United States.; Department of Medicine, Boston University School of Medicine, Boston, MA, United States., Claxton DF; Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA, United States., Ehmann WC; Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA, United States., Drabick JJ; Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA, United States., Li H; Department of Biosystems Engineering, University of Arizona, Tucson, AZ, United States., Loughran TP Jr; Department of Medicine, University of Virginia National Cancer Institute (NCI) Designated Comprehensive Cancer Center, Charlottesville, VA, United States., Epner EM; Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA, United States.
Source: Frontiers in oncology [Front Oncol] 2024 Dec 16; Vol. 14, pp. 1449401. Date of Electronic Publication: 2024 Dec 16 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39737396
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pu+JJ%22">Pu JJ</searchLink>; Division of Medicine, VA Boston Healthcare System, Boston, MA, United States.; Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Berger+KN%22">Berger KN</searchLink>; New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Zheng+C%22">Zheng C</searchLink>; Division of Medicine, VA Boston Healthcare System, Boston, MA, United States.; Department of Medicine, Boston University School of Medicine, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Do+N%22">Do N</searchLink>; Division of Medicine, VA Boston Healthcare System, Boston, MA, United States.; Department of Medicine, Boston University School of Medicine, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Claxton+DF%22">Claxton DF</searchLink>; Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA, United States.<br /><searchLink fieldCode="AU" term="%22Ehmann+WC%22">Ehmann WC</searchLink>; Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA, United States.<br /><searchLink fieldCode="AU" term="%22Drabick+JJ%22">Drabick JJ</searchLink>; Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA, United States.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Department of Biosystems Engineering, University of Arizona, Tucson, AZ, United States.<br /><searchLink fieldCode="AU" term="%22Loughran+TP+Jr%22">Loughran TP Jr</searchLink>; Department of Medicine, University of Virginia National Cancer Institute (NCI) Designated Comprehensive Cancer Center, Charlottesville, VA, United States.<br /><searchLink fieldCode="AU" term="%22Epner+EM%22">Epner EM</searchLink>; Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 Dec 16; Vol. 14, pp. 1449401. <i>Date of Electronic Publication: </i>2024 Dec 16 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39737396
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2024.1449401
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1449401
    Titles:
      – TitleFull: A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pu JJ
      – PersonEntity:
          Name:
            NameFull: Berger KN
      – PersonEntity:
          Name:
            NameFull: Zheng C
      – PersonEntity:
          Name:
            NameFull: Do N
      – PersonEntity:
          Name:
            NameFull: Claxton DF
      – PersonEntity:
          Name:
            NameFull: Ehmann WC
      – PersonEntity:
          Name:
            NameFull: Drabick JJ
      – PersonEntity:
          Name:
            NameFull: Li H
      – PersonEntity:
          Name:
            NameFull: Loughran TP Jr
      – PersonEntity:
          Name:
            NameFull: Epner EM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 12
              Text: 2024 Dec 16
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1